Companies / SOPHiA GENETICS SA

SOPHiA GENETICS SA

Nasdaq: SOPHForeign · IFRSCIK 1840706ROLLE

Financials · FY2025

Revenue$77.27M
Net income$-79.00M
Total debt
Cash$70.29M
Diluted EPS$-1.17
Shares outstanding68.5M

Ownership

68.5M shares outstanding
100.0%Public float
Ownership
Public float100.00%68,486,338

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 15

View all →
Insider% of sharesShares
Camblong JurgiCEOChief Executive Officer · Director
Cardoza GeorgeChief Financial Officer
Cox TroyDirector
Menu PhilippeChief Medical Officer
Muken RossPresident

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 18, 2026Hibbs Kathy L
Director
GrantOrdinary Shares$107.7K+20K
+21.97%
109,492
0.16% of shares
low
Jun 18, 2026Hirsch Didier
Director
GrantOrdinary Shares$107.7K+20K
+8.95%
240,220
0.35% of shares
low
May 12, 2026Hibbs Kathy L
Director
SellOrdinary Shares$35.0K-8K
-7.72%
89,768
0.13% of shares
low
Mar 19, 2026Camblong Jurgi
CEO
SellOrdinary Shares$21.4K-4K
-0.14%
3,302,839
4.82% of shares
low
Mar 19, 2026Muken Ross
Executive
SellOrdinary Shares$5.7K-1K
-0.43%
271,910
0.40% of shares
low
Mar 19, 2026Cardoza George
Executive
SellOrdinary Shares$3.7K-774
-0.42%
184,858
0.27% of shares
low
Mar 19, 2026Van Well Daan
Executive
SellOrdinary Shares$3.3K-684
-0.26%
261,238
0.38% of shares
low
Mar 19, 2026Menu Philippe
Executive
SellOrdinary Shares$2.9K-608
-0.35%
173,616
0.25% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Balderton Capital VI, S.L.P.Passive13G/A